Skip navigation

Chemical Phosphoramides

1–50 of 268 results.
  Chemical Phenotype Co-Mentioned Terms Interaction Organisms Anatomy Inference Network References
1. 4-hydroxycyclophosphamide apoptotic process 4-hydroxycyclophosphamide results in increased apoptotic process 1: Rattus norvegicus Ovarian Follicle 1 gene: MAPK14 1
2. 4-hydroxycyclophosphamide apoptotic process afimoxifene afimoxifene inhibits the reaction [4-hydroxycyclophosphamide results in increased apoptotic process] 1: Rattus norvegicus Ovarian Follicle 1 gene: MAPK14 1
3. 4-hydroxyperoxycyclophosphamide apoptotic process NAc-Sar-Gly-Val-(d-allo-Ile)-Thr-Nva-Ile-Arg-ProNEt 4-hydroxyperoxycyclophosphamide promotes the reaction [NAc-Sar-Gly-Val-(d-allo-Ile)-Thr-Nva-Ile-Arg-ProNEt results in increased apoptotic process] 1: Homo sapiens Endothelial Cells   1
4. acephate triglyceride biosynthetic process acephate results in increased triglyceride biosynthetic process 1: Rattus norvegicus Plasma   1
5. acephate gluconeogenesis diphenyldiselenide diphenyldiselenide inhibits the reaction [acephate results in increased gluconeogenesis] 1: Rattus norvegicus Plasma
2 genes: G6PC | TAT
1
6. acephate gluconeogenesis acephate results in increased gluconeogenesis 1: Rattus norvegicus Plasma
2 genes: G6PC | TAT
1
7. acephate triglyceride biosynthetic process diphenyldiselenide diphenyldiselenide inhibits the reaction [acephate results in increased triglyceride biosynthetic process] 1: Rattus norvegicus Plasma   1
8. acephate cognition acephate results in decreased cognition 1: Homo sapiens     1
9. acephate negative regulation of cell proliferation Aldosterone acephate inhibits the reaction [Aldosterone results in increased negative regulation of cell proliferation] 1: Homo sapiens Liver | Cell Line, Tumor   1
10. acephate mineralocorticoid receptor signaling pathway Aldosterone acephate inhibits the reaction [Aldosterone results in increased mineralocorticoid receptor signaling pathway] 1: Homo sapiens Muscle, Smooth, Vascular | Cells, Cultured 1 gene: NR3C2 1
11. acephate mineralocorticoid receptor activity Aldosterone acephate inhibits the reaction [Aldosterone results in increased mineralocorticoid receptor activity] 1: Homo sapiens Muscle, Smooth, Vascular | Cells, Cultured 1 gene: NR3C2 1
12. beta-D-glucosylisophosphoramide mustard cell proliferation beta-D-glucosylisophosphoramide mustard results in decreased cell proliferation 1: Homo sapiens Pancreas | Cell Line, Tumor   1
13. beta-D-glucosylisophosphoramide mustard apoptotic process beta-D-glucosylisophosphoramide mustard results in increased apoptotic process 1: Homo sapiens Pancreas | Cell Line, Tumor   1
14. beta-D-glucosylisophosphoramide mustard apoptotic DNA fragmentation beta-D-glucosylisophosphoramide mustard results in increased apoptotic DNA fragmentation 1: Homo sapiens Pancreas | Cell Line, Tumor   1
15. CISCA protocol apoptotic process CISCA protocol results in increased apoptotic process 1: Homo sapiens Blood | Lymphocytes   1
16. CISCA protocol apoptotic DNA fragmentation CISCA protocol results in increased apoptotic DNA fragmentation 1: Homo sapiens Blood | Lymphocytes   1
17. CISCA protocol apoptotic process Amifostine Amifostine inhibits the reaction [CISCA protocol results in increased apoptotic process] 1: Homo sapiens Blood | Lymphocytes   1
18. Cyclophosphamide cell cycle Cyclophosphamide affects cell cycle 1: Cricetulus griseus Lung | Fibroblasts | Cell Line
33 genes: AURKB | BECN1 | BUB3 | CCNA2 | CCND2 | CCND3 | CDC20 | CDK2 | CDKN1A | CDKN1B | CDKN1C | CDKN2D | DDIT3 | E2F3 | EPB41L2 | GADD45A | GAS2 | MAPK1 | MAPK3 | MAPK7 | MCM5 | MELK | MLH1 | MSH2 | NASP | PARD3 | PTP4A1 | RAD50 | RPS3 | TP53 | TRP53 | USP44 | ZFP385A
1
19. Cyclophosphamide membrane lipid catabolic process Cyclophosphamide results in increased membrane lipid catabolic process 1: Rattus norvegicus Kidney 1 gene: CYP1B1 1
20. Cyclophosphamide response to oxidative stress Cyclophosphamide results in increased response to oxidative stress 1: Rattus norvegicus Urinary Bladder
39 genes: ABCC1 | AKT1 | ALAD | ALDH1A1 | APOE | BCL2 | BCL2L1 | BTG1 | BTG3 | CAT | DDIT3 | EGFR | ERCC1 | ERCC2 | GCLC | GPX1 | GPX3 | GPX4 | GSR | HMOX1 | HMOX2 | LCN2 | MPO | NDUFS2 | NQO1 | OGG1 | PCNA | PTGS1 | PTGS2 | RBPMS | RPS3 | RRM2B | SLC7A11 | SOD1 | SOD2 | TAT | TP53 | TRP53 | TXNRD1
1
21. Cyclophosphamide membrane lipid catabolic process Cyclophosphamide results in increased membrane lipid catabolic process 1: Rattus norvegicus Urinary Bladder 1 gene: CYP1B1 1
22. Cyclophosphamide membrane lipid catabolic process Cyclophosphamide results in increased membrane lipid catabolic process 1: Rattus norvegicus Liver 1 gene: CYP1B1 1
23. Cyclophosphamide membrane lipid catabolic process Cyclophosphamide results in increased membrane lipid catabolic process 1: Mus musculus Tumor Cells, Cultured 1 gene: CYP1B1 1
24. Cyclophosphamide membrane lipid catabolic process Plant Extracts [Plant Extracts co-treated with Cyclophosphamide] results in increased membrane lipid catabolic process 1: Mus musculus Tumor Cells, Cultured 1 gene: CYP1B1 1
25. Cyclophosphamide apoptotic process Cyclophosphamide results in increased apoptotic process 1: Mus musculus Hair Follicle | Keratinocytes
75 genes: AKT1 | BAD | BAG1 | BAX | BCL2 | BCL2L1 | BCL2L2 | BECN1 | BIK | BIRC3 | CASP1 | CASP3 | CASP8 | CASP9 | CD14 | CD2 | CD27 | CHAC1 | CTSH | CXCR4 | DDIT3 | DDIT4 | DLC1 | EPO | ERBB4 | ERCC2 | FAS | FASLG | GADD45A | GAS2 | GJA1 | GPX1 | GZMA | GZMB | HMOX1 | IER3 | IFIT2 | IFNG | IGFBP3 | IL17A | IL1A | IL1B | LCK | LCN2 | LGALS1 | LGALS7 | LMNB1 | LTBR | MAPK1 | MAPK14 | MAPK3 | MAPT | MELK | NAIP | NGFR | PARP1 | PDCD4 | PHLDA2 | PURA | RNF216 | RPS3 | RRAGA | SGK1 | STK4 | TGFBR2 | TNF | TNFAIP3 | TNFRSF18 | TNFSF9 | TP53 | TRIB3 | TRP53 | XAF1 | ZFP36L1 | ZFP385A
1
26. Cyclophosphamide apoptotic process Calcitriol Calcitriol inhibits the reaction [Cyclophosphamide results in increased apoptotic process] 1: Mus musculus Hair Follicle | Keratinocytes
75 genes: AKT1 | BAD | BAG1 | BAX | BCL2 | BCL2L1 | BCL2L2 | BECN1 | BIK | BIRC3 | CASP1 | CASP3 | CASP8 | CASP9 | CD14 | CD2 | CD27 | CHAC1 | CTSH | CXCR4 | DDIT3 | DDIT4 | DLC1 | EPO | ERBB4 | ERCC2 | FAS | FASLG | GADD45A | GAS2 | GJA1 | GPX1 | GZMA | GZMB | HMOX1 | IER3 | IFIT2 | IFNG | IGFBP3 | IL17A | IL1A | IL1B | LCK | LCN2 | LGALS1 | LGALS7 | LMNB1 | LTBR | MAPK1 | MAPK14 | MAPK3 | MAPT | MELK | NAIP | NGFR | PARP1 | PDCD4 | PHLDA2 | PURA | RNF216 | RPS3 | RRAGA | SGK1 | STK4 | TGFBR2 | TNF | TNFAIP3 | TNFRSF18 | TNFSF9 | TP53 | TRIB3 | TRP53 | XAF1 | ZFP36L1 | ZFP385A
1
27. Cyclophosphamide apoptotic process Cyclophosphamide results in increased apoptotic process 1: Rattus norvegicus Granulosa Cells
75 genes: AKT1 | BAD | BAG1 | BAX | BCL2 | BCL2L1 | BCL2L2 | BECN1 | BIK | BIRC3 | CASP1 | CASP3 | CASP8 | CASP9 | CD14 | CD2 | CD27 | CHAC1 | CTSH | CXCR4 | DDIT3 | DDIT4 | DLC1 | EPO | ERBB4 | ERCC2 | FAS | FASLG | GADD45A | GAS2 | GJA1 | GPX1 | GZMA | GZMB | HMOX1 | IER3 | IFIT2 | IFNG | IGFBP3 | IL17A | IL1A | IL1B | LCK | LCN2 | LGALS1 | LGALS7 | LMNB1 | LTBR | MAPK1 | MAPK14 | MAPK3 | MAPT | MELK | NAIP | NGFR | PARP1 | PDCD4 | PHLDA2 | PURA | RNF216 | RPS3 | RRAGA | SGK1 | STK4 | TGFBR2 | TNF | TNFAIP3 | TNFRSF18 | TNFSF9 | TP53 | TRIB3 | TRP53 | XAF1 | ZFP36L1 | ZFP385A
2
28. Cyclophosphamide apoptotic process cetrorelix cetrorelix inhibits the reaction [Cyclophosphamide results in increased apoptotic process] 1: Rattus norvegicus Granulosa Cells
75 genes: AKT1 | BAD | BAG1 | BAX | BCL2 | BCL2L1 | BCL2L2 | BECN1 | BIK | BIRC3 | CASP1 | CASP3 | CASP8 | CASP9 | CD14 | CD2 | CD27 | CHAC1 | CTSH | CXCR4 | DDIT3 | DDIT4 | DLC1 | EPO | ERBB4 | ERCC2 | FAS | FASLG | GADD45A | GAS2 | GJA1 | GPX1 | GZMA | GZMB | HMOX1 | IER3 | IFIT2 | IFNG | IGFBP3 | IL17A | IL1A | IL1B | LCK | LCN2 | LGALS1 | LGALS7 | LMNB1 | LTBR | MAPK1 | MAPK14 | MAPK3 | MAPT | MELK | NAIP | NGFR | PARP1 | PDCD4 | PHLDA2 | PURA | RNF216 | RPS3 | RRAGA | SGK1 | STK4 | TGFBR2 | TNF | TNFAIP3 | TNFRSF18 | TNFSF9 | TP53 | TRIB3 | TRP53 | XAF1 | ZFP36L1 | ZFP385A
1
29. Cyclophosphamide apoptotic process Cyclophosphamide results in increased apoptotic process 1: Mus musculus Limb Buds
75 genes: AKT1 | BAD | BAG1 | BAX | BCL2 | BCL2L1 | BCL2L2 | BECN1 | BIK | BIRC3 | CASP1 | CASP3 | CASP8 | CASP9 | CD14 | CD2 | CD27 | CHAC1 | CTSH | CXCR4 | DDIT3 | DDIT4 | DLC1 | EPO | ERBB4 | ERCC2 | FAS | FASLG | GADD45A | GAS2 | GJA1 | GPX1 | GZMA | GZMB | HMOX1 | IER3 | IFIT2 | IFNG | IGFBP3 | IL17A | IL1A | IL1B | LCK | LCN2 | LGALS1 | LGALS7 | LMNB1 | LTBR | MAPK1 | MAPK14 | MAPK3 | MAPT | MELK | NAIP | NGFR | PARP1 | PDCD4 | PHLDA2 | PURA | RNF216 | RPS3 | RRAGA | SGK1 | STK4 | TGFBR2 | TNF | TNFAIP3 | TNFRSF18 | TNFSF9 | TP53 | TRIB3 | TRP53 | XAF1 | ZFP36L1 | ZFP385A
1
30. Cyclophosphamide apoptotic process Cyclophosphamide results in increased apoptotic process 1: Rattus norvegicus Seminiferous Tubules | Spermatogonia
75 genes: AKT1 | BAD | BAG1 | BAX | BCL2 | BCL2L1 | BCL2L2 | BECN1 | BIK | BIRC3 | CASP1 | CASP3 | CASP8 | CASP9 | CD14 | CD2 | CD27 | CHAC1 | CTSH | CXCR4 | DDIT3 | DDIT4 | DLC1 | EPO | ERBB4 | ERCC2 | FAS | FASLG | GADD45A | GAS2 | GJA1 | GPX1 | GZMA | GZMB | HMOX1 | IER3 | IFIT2 | IFNG | IGFBP3 | IL17A | IL1A | IL1B | LCK | LCN2 | LGALS1 | LGALS7 | LMNB1 | LTBR | MAPK1 | MAPK14 | MAPK3 | MAPT | MELK | NAIP | NGFR | PARP1 | PDCD4 | PHLDA2 | PURA | RNF216 | RPS3 | RRAGA | SGK1 | STK4 | TGFBR2 | TNF | TNFAIP3 | TNFRSF18 | TNFSF9 | TP53 | TRIB3 | TRP53 | XAF1 | ZFP36L1 | ZFP385A
1
31. Cyclophosphamide apoptotic process Cyclophosphamide results in increased apoptotic process 1: Rattus norvegicus Seminiferous Tubules | Spermatocytes
75 genes: AKT1 | BAD | BAG1 | BAX | BCL2 | BCL2L1 | BCL2L2 | BECN1 | BIK | BIRC3 | CASP1 | CASP3 | CASP8 | CASP9 | CD14 | CD2 | CD27 | CHAC1 | CTSH | CXCR4 | DDIT3 | DDIT4 | DLC1 | EPO | ERBB4 | ERCC2 | FAS | FASLG | GADD45A | GAS2 | GJA1 | GPX1 | GZMA | GZMB | HMOX1 | IER3 | IFIT2 | IFNG | IGFBP3 | IL17A | IL1A | IL1B | LCK | LCN2 | LGALS1 | LGALS7 | LMNB1 | LTBR | MAPK1 | MAPK14 | MAPK3 | MAPT | MELK | NAIP | NGFR | PARP1 | PDCD4 | PHLDA2 | PURA | RNF216 | RPS3 | RRAGA | SGK1 | STK4 | TGFBR2 | TNF | TNFAIP3 | TNFRSF18 | TNFSF9 | TP53 | TRIB3 | TRP53 | XAF1 | ZFP36L1 | ZFP385A
1
32. Cyclophosphamide cell proliferation Cyclophosphamide results in decreased cell proliferation 1: Mus musculus Cornea
53 genes: ACE | AKT1 | AURKB | BAD | BAX | BCL2 | BCL2L1 | CD5 | CD74 | CFB | CHRM5 | CITED2 | CSF1 | CXCL1 | CYP1A1 | DDIT4 | EGFR | EMP1 | EPO | ERBB2 | ERBB4 | ERCC1 | ERCC2 | ERG | FSCN1 | GDNF | GPX1 | IGFBP4 | IL12A | IL12B | IL15RA | IL18 | IL1A | KDM1A | MELK | MIF | MYH10 | NASP | NRG1 | OSM | PCNA | PTGES3 | PURA | REG3A | STAT3 | TGFB1 | TGFB2 | TNFSF9 | TOP2A | TP53 | TXNRD1 | VEGFA | ZFP36L1
1
33. Cyclophosphamide apoptotic process Cyclophosphamide results in increased apoptotic process 1: Mus musculus Endothelial Cells
75 genes: AKT1 | BAD | BAG1 | BAX | BCL2 | BCL2L1 | BCL2L2 | BECN1 | BIK | BIRC3 | CASP1 | CASP3 | CASP8 | CASP9 | CD14 | CD2 | CD27 | CHAC1 | CTSH | CXCR4 | DDIT3 | DDIT4 | DLC1 | EPO | ERBB4 | ERCC2 | FAS | FASLG | GADD45A | GAS2 | GJA1 | GPX1 | GZMA | GZMB | HMOX1 | IER3 | IFIT2 | IFNG | IGFBP3 | IL17A | IL1A | IL1B | LCK | LCN2 | LGALS1 | LGALS7 | LMNB1 | LTBR | MAPK1 | MAPK14 | MAPK3 | MAPT | MELK | NAIP | NGFR | PARP1 | PDCD4 | PHLDA2 | PURA | RNF216 | RPS3 | RRAGA | SGK1 | STK4 | TGFBR2 | TNF | TNFAIP3 | TNFRSF18 | TNFSF9 | TP53 | TRIB3 | TRP53 | XAF1 | ZFP36L1 | ZFP385A
1
34. Cyclophosphamide apoptotic process Cyclophosphamide results in increased apoptotic process 2: Mus musculus | Rattus norvegicus  
75 genes: AKT1 | BAD | BAG1 | BAX | BCL2 | BCL2L1 | BCL2L2 | BECN1 | BIK | BIRC3 | CASP1 | CASP3 | CASP8 | CASP9 | CD14 | CD2 | CD27 | CHAC1 | CTSH | CXCR4 | DDIT3 | DDIT4 | DLC1 | EPO | ERBB4 | ERCC2 | FAS | FASLG | GADD45A | GAS2 | GJA1 | GPX1 | GZMA | GZMB | HMOX1 | IER3 | IFIT2 | IFNG | IGFBP3 | IL17A | IL1A | IL1B | LCK | LCN2 | LGALS1 | LGALS7 | LMNB1 | LTBR | MAPK1 | MAPK14 | MAPK3 | MAPT | MELK | NAIP | NGFR | PARP1 | PDCD4 | PHLDA2 | PURA | RNF216 | RPS3 | RRAGA | SGK1 | STK4 | TGFBR2 | TNF | TNFAIP3 | TNFRSF18 | TNFSF9 | TP53 | TRIB3 | TRP53 | XAF1 | ZFP36L1 | ZFP385A
2
35. Cyclophosphamide apoptotic process TRP53 TRP53 affects the reaction [Cyclophosphamide results in increased apoptotic process] 1: Mus musculus  
75 genes: AKT1 | BAD | BAG1 | BAX | BCL2 | BCL2L1 | BCL2L2 | BECN1 | BIK | BIRC3 | CASP1 | CASP3 | CASP8 | CASP9 | CD14 | CD2 | CD27 | CHAC1 | CTSH | CXCR4 | DDIT3 | DDIT4 | DLC1 | EPO | ERBB4 | ERCC2 | FAS | FASLG | GADD45A | GAS2 | GJA1 | GPX1 | GZMA | GZMB | HMOX1 | IER3 | IFIT2 | IFNG | IGFBP3 | IL17A | IL1A | IL1B | LCK | LCN2 | LGALS1 | LGALS7 | LMNB1 | LTBR | MAPK1 | MAPK14 | MAPK3 | MAPT | MELK | NAIP | NGFR | PARP1 | PDCD4 | PHLDA2 | PURA | RNF216 | RPS3 | RRAGA | SGK1 | STK4 | TGFBR2 | TNF | TNFAIP3 | TNFRSF18 | TNFSF9 | TP53 | TRIB3 | TRP53 | XAF1 | ZFP36L1 | ZFP385A
1
36. Cyclophosphamide apoptotic process TRP53 TRP53 affects the reaction [Cyclophosphamide results in increased apoptotic process] 1: Mus musculus Endothelial Cells
75 genes: AKT1 | BAD | BAG1 | BAX | BCL2 | BCL2L1 | BCL2L2 | BECN1 | BIK | BIRC3 | CASP1 | CASP3 | CASP8 | CASP9 | CD14 | CD2 | CD27 | CHAC1 | CTSH | CXCR4 | DDIT3 | DDIT4 | DLC1 | EPO | ERBB4 | ERCC2 | FAS | FASLG | GADD45A | GAS2 | GJA1 | GPX1 | GZMA | GZMB | HMOX1 | IER3 | IFIT2 | IFNG | IGFBP3 | IL17A | IL1A | IL1B | LCK | LCN2 | LGALS1 | LGALS7 | LMNB1 | LTBR | MAPK1 | MAPK14 | MAPK3 | MAPT | MELK | NAIP | NGFR | PARP1 | PDCD4 | PHLDA2 | PURA | RNF216 | RPS3 | RRAGA | SGK1 | STK4 | TGFBR2 | TNF | TNFAIP3 | TNFRSF18 | TNFSF9 | TP53 | TRIB3 | TRP53 | XAF1 | ZFP36L1 | ZFP385A
1
37. Cyclophosphamide apoptotic process CYP2B6 | PARP1 [[CYP2B6 protein results in increased activity of Cyclophosphamide] which results in increased apoptotic process] which results in increased cleavage of PARP1 protein 1: Rattus norvegicus Neuroglia | Cell Line, Tumor
75 genes: AKT1 | BAD | BAG1 | BAX | BCL2 | BCL2L1 | BCL2L2 | BECN1 | BIK | BIRC3 | CASP1 | CASP3 | CASP8 | CASP9 | CD14 | CD2 | CD27 | CHAC1 | CTSH | CXCR4 | DDIT3 | DDIT4 | DLC1 | EPO | ERBB4 | ERCC2 | FAS | FASLG | GADD45A | GAS2 | GJA1 | GPX1 | GZMA | GZMB | HMOX1 | IER3 | IFIT2 | IFNG | IGFBP3 | IL17A | IL1A | IL1B | LCK | LCN2 | LGALS1 | LGALS7 | LMNB1 | LTBR | MAPK1 | MAPK14 | MAPK3 | MAPT | MELK | NAIP | NGFR | PARP1 | PDCD4 | PHLDA2 | PURA | RNF216 | RPS3 | RRAGA | SGK1 | STK4 | TGFBR2 | TNF | TNFAIP3 | TNFRSF18 | TNFSF9 | TP53 | TRIB3 | TRP53 | XAF1 | ZFP36L1 | ZFP385A
1
38. Cyclophosphamide apoptotic DNA fragmentation CYP2B6 [CYP2B6 protein results in increased activity of Cyclophosphamide] which results in increased apoptotic DNA fragmentation 1: Rattus norvegicus Neuroglia | Cell Line, Tumor 1 gene: CASP3 1
39. Cyclophosphamide apoptotic process CASP3 | CYP2B6 [[CYP2B6 protein results in increased activity of Cyclophosphamide] which results in increased apoptotic process] which results in increased cleavage of CASP3 protein 1: Rattus norvegicus Neuroglia | Cell Line, Tumor
75 genes: AKT1 | BAD | BAG1 | BAX | BCL2 | BCL2L1 | BCL2L2 | BECN1 | BIK | BIRC3 | CASP1 | CASP3 | CASP8 | CASP9 | CD14 | CD2 | CD27 | CHAC1 | CTSH | CXCR4 | DDIT3 | DDIT4 | DLC1 | EPO | ERBB4 | ERCC2 | FAS | FASLG | GADD45A | GAS2 | GJA1 | GPX1 | GZMA | GZMB | HMOX1 | IER3 | IFIT2 | IFNG | IGFBP3 | IL17A | IL1A | IL1B | LCK | LCN2 | LGALS1 | LGALS7 | LMNB1 | LTBR | MAPK1 | MAPK14 | MAPK3 | MAPT | MELK | NAIP | NGFR | PARP1 | PDCD4 | PHLDA2 | PURA | RNF216 | RPS3 | RRAGA | SGK1 | STK4 | TGFBR2 | TNF | TNFAIP3 | TNFRSF18 | TNFSF9 | TP53 | TRIB3 | TRP53 | XAF1 | ZFP36L1 | ZFP385A
1
40. Cyclophosphamide apoptotic process CYP2B6 [CYP2B6 protein results in increased activity of Cyclophosphamide] which results in increased apoptotic process 1: Rattus norvegicus Neuroglia | Cell Line, Tumor
75 genes: AKT1 | BAD | BAG1 | BAX | BCL2 | BCL2L1 | BCL2L2 | BECN1 | BIK | BIRC3 | CASP1 | CASP3 | CASP8 | CASP9 | CD14 | CD2 | CD27 | CHAC1 | CTSH | CXCR4 | DDIT3 | DDIT4 | DLC1 | EPO | ERBB4 | ERCC2 | FAS | FASLG | GADD45A | GAS2 | GJA1 | GPX1 | GZMA | GZMB | HMOX1 | IER3 | IFIT2 | IFNG | IGFBP3 | IL17A | IL1A | IL1B | LCK | LCN2 | LGALS1 | LGALS7 | LMNB1 | LTBR | MAPK1 | MAPK14 | MAPK3 | MAPT | MELK | NAIP | NGFR | PARP1 | PDCD4 | PHLDA2 | PURA | RNF216 | RPS3 | RRAGA | SGK1 | STK4 | TGFBR2 | TNF | TNFAIP3 | TNFRSF18 | TNFSF9 | TP53 | TRIB3 | TRP53 | XAF1 | ZFP36L1 | ZFP385A
1
41. Cyclophosphamide apoptotic process CASP9 | CYP2B6 [[CYP2B6 protein results in increased activity of Cyclophosphamide] which results in increased apoptotic process] which results in increased activity of CASP9 protein 1: Rattus norvegicus Neuroglia | Cell Line, Tumor
75 genes: AKT1 | BAD | BAG1 | BAX | BCL2 | BCL2L1 | BCL2L2 | BECN1 | BIK | BIRC3 | CASP1 | CASP3 | CASP8 | CASP9 | CD14 | CD2 | CD27 | CHAC1 | CTSH | CXCR4 | DDIT3 | DDIT4 | DLC1 | EPO | ERBB4 | ERCC2 | FAS | FASLG | GADD45A | GAS2 | GJA1 | GPX1 | GZMA | GZMB | HMOX1 | IER3 | IFIT2 | IFNG | IGFBP3 | IL17A | IL1A | IL1B | LCK | LCN2 | LGALS1 | LGALS7 | LMNB1 | LTBR | MAPK1 | MAPK14 | MAPK3 | MAPT | MELK | NAIP | NGFR | PARP1 | PDCD4 | PHLDA2 | PURA | RNF216 | RPS3 | RRAGA | SGK1 | STK4 | TGFBR2 | TNF | TNFAIP3 | TNFRSF18 | TNFSF9 | TP53 | TRIB3 | TRP53 | XAF1 | ZFP36L1 | ZFP385A
1
42. Cyclophosphamide apoptotic process CASP8 | CYP2B6 [[CYP2B6 protein results in increased activity of Cyclophosphamide] which results in increased apoptotic process] which results in increased activity of CASP8 protein 1: Rattus norvegicus Neuroglia | Cell Line, Tumor
75 genes: AKT1 | BAD | BAG1 | BAX | BCL2 | BCL2L1 | BCL2L2 | BECN1 | BIK | BIRC3 | CASP1 | CASP3 | CASP8 | CASP9 | CD14 | CD2 | CD27 | CHAC1 | CTSH | CXCR4 | DDIT3 | DDIT4 | DLC1 | EPO | ERBB4 | ERCC2 | FAS | FASLG | GADD45A | GAS2 | GJA1 | GPX1 | GZMA | GZMB | HMOX1 | IER3 | IFIT2 | IFNG | IGFBP3 | IL17A | IL1A | IL1B | LCK | LCN2 | LGALS1 | LGALS7 | LMNB1 | LTBR | MAPK1 | MAPK14 | MAPK3 | MAPT | MELK | NAIP | NGFR | PARP1 | PDCD4 | PHLDA2 | PURA | RNF216 | RPS3 | RRAGA | SGK1 | STK4 | TGFBR2 | TNF | TNFAIP3 | TNFRSF18 | TNFSF9 | TP53 | TRIB3 | TRP53 | XAF1 | ZFP36L1 | ZFP385A
1
43. Cyclophosphamide apoptotic process Cyclophosphamide results in increased apoptotic process 1: Mus musculus Lymphoid Tissue
75 genes: AKT1 | BAD | BAG1 | BAX | BCL2 | BCL2L1 | BCL2L2 | BECN1 | BIK | BIRC3 | CASP1 | CASP3 | CASP8 | CASP9 | CD14 | CD2 | CD27 | CHAC1 | CTSH | CXCR4 | DDIT3 | DDIT4 | DLC1 | EPO | ERBB4 | ERCC2 | FAS | FASLG | GADD45A | GAS2 | GJA1 | GPX1 | GZMA | GZMB | HMOX1 | IER3 | IFIT2 | IFNG | IGFBP3 | IL17A | IL1A | IL1B | LCK | LCN2 | LGALS1 | LGALS7 | LMNB1 | LTBR | MAPK1 | MAPK14 | MAPK3 | MAPT | MELK | NAIP | NGFR | PARP1 | PDCD4 | PHLDA2 | PURA | RNF216 | RPS3 | RRAGA | SGK1 | STK4 | TGFBR2 | TNF | TNFAIP3 | TNFRSF18 | TNFSF9 | TP53 | TRIB3 | TRP53 | XAF1 | ZFP36L1 | ZFP385A
1
44. Cyclophosphamide apoptotic process MCL1 [MCL1 mutant form co-treated with Cyclophosphamide] results in increased apoptotic process 1: Homo sapiens  
75 genes: AKT1 | BAD | BAG1 | BAX | BCL2 | BCL2L1 | BCL2L2 | BECN1 | BIK | BIRC3 | CASP1 | CASP3 | CASP8 | CASP9 | CD14 | CD2 | CD27 | CHAC1 | CTSH | CXCR4 | DDIT3 | DDIT4 | DLC1 | EPO | ERBB4 | ERCC2 | FAS | FASLG | GADD45A | GAS2 | GJA1 | GPX1 | GZMA | GZMB | HMOX1 | IER3 | IFIT2 | IFNG | IGFBP3 | IL17A | IL1A | IL1B | LCK | LCN2 | LGALS1 | LGALS7 | LMNB1 | LTBR | MAPK1 | MAPK14 | MAPK3 | MAPT | MELK | NAIP | NGFR | PARP1 | PDCD4 | PHLDA2 | PURA | RNF216 | RPS3 | RRAGA | SGK1 | STK4 | TGFBR2 | TNF | TNFAIP3 | TNFRSF18 | TNFSF9 | TP53 | TRIB3 | TRP53 | XAF1 | ZFP36L1 | ZFP385A
1
45. Cyclophosphamide apoptotic process Cladribine [Cladribine co-treated with Cyclophosphamide] results in increased apoptotic process 1: Homo sapiens Blood Cells
75 genes: AKT1 | BAD | BAG1 | BAX | BCL2 | BCL2L1 | BCL2L2 | BECN1 | BIK | BIRC3 | CASP1 | CASP3 | CASP8 | CASP9 | CD14 | CD2 | CD27 | CHAC1 | CTSH | CXCR4 | DDIT3 | DDIT4 | DLC1 | EPO | ERBB4 | ERCC2 | FAS | FASLG | GADD45A | GAS2 | GJA1 | GPX1 | GZMA | GZMB | HMOX1 | IER3 | IFIT2 | IFNG | IGFBP3 | IL17A | IL1A | IL1B | LCK | LCN2 | LGALS1 | LGALS7 | LMNB1 | LTBR | MAPK1 | MAPK14 | MAPK3 | MAPT | MELK | NAIP | NGFR | PARP1 | PDCD4 | PHLDA2 | PURA | RNF216 | RPS3 | RRAGA | SGK1 | STK4 | TGFBR2 | TNF | TNFAIP3 | TNFRSF18 | TNFSF9 | TP53 | TRIB3 | TRP53 | XAF1 | ZFP36L1 | ZFP385A
1
46. Cyclophosphamide apoptotic process Cladribine | Mitoxantrone [Cladribine co-treated with Cyclophosphamide co-treated with Mitoxantrone] results in increased apoptotic process 1: Homo sapiens Blood Cells
75 genes: AKT1 | BAD | BAG1 | BAX | BCL2 | BCL2L1 | BCL2L2 | BECN1 | BIK | BIRC3 | CASP1 | CASP3 | CASP8 | CASP9 | CD14 | CD2 | CD27 | CHAC1 | CTSH | CXCR4 | DDIT3 | DDIT4 | DLC1 | EPO | ERBB4 | ERCC2 | FAS | FASLG | GADD45A | GAS2 | GJA1 | GPX1 | GZMA | GZMB | HMOX1 | IER3 | IFIT2 | IFNG | IGFBP3 | IL17A | IL1A | IL1B | LCK | LCN2 | LGALS1 | LGALS7 | LMNB1 | LTBR | MAPK1 | MAPK14 | MAPK3 | MAPT | MELK | NAIP | NGFR | PARP1 | PDCD4 | PHLDA2 | PURA | RNF216 | RPS3 | RRAGA | SGK1 | STK4 | TGFBR2 | TNF | TNFAIP3 | TNFRSF18 | TNFSF9 | TP53 | TRIB3 | TRP53 | XAF1 | ZFP36L1 | ZFP385A
1
47. Cyclophosphamide apoptotic process Cyclophosphamide results in increased apoptotic process 1: Homo sapiens Human Umbilical Vein Endothelial Cells
75 genes: AKT1 | BAD | BAG1 | BAX | BCL2 | BCL2L1 | BCL2L2 | BECN1 | BIK | BIRC3 | CASP1 | CASP3 | CASP8 | CASP9 | CD14 | CD2 | CD27 | CHAC1 | CTSH | CXCR4 | DDIT3 | DDIT4 | DLC1 | EPO | ERBB4 | ERCC2 | FAS | FASLG | GADD45A | GAS2 | GJA1 | GPX1 | GZMA | GZMB | HMOX1 | IER3 | IFIT2 | IFNG | IGFBP3 | IL17A | IL1A | IL1B | LCK | LCN2 | LGALS1 | LGALS7 | LMNB1 | LTBR | MAPK1 | MAPK14 | MAPK3 | MAPT | MELK | NAIP | NGFR | PARP1 | PDCD4 | PHLDA2 | PURA | RNF216 | RPS3 | RRAGA | SGK1 | STK4 | TGFBR2 | TNF | TNFAIP3 | TNFRSF18 | TNFSF9 | TP53 | TRIB3 | TRP53 | XAF1 | ZFP36L1 | ZFP385A
1
48. Cyclophosphamide apoptotic process Cyclophosphamide results in increased apoptotic process 1: Homo sapiens Prostate | Cell Line, Tumor
75 genes: AKT1 | BAD | BAG1 | BAX | BCL2 | BCL2L1 | BCL2L2 | BECN1 | BIK | BIRC3 | CASP1 | CASP3 | CASP8 | CASP9 | CD14 | CD2 | CD27 | CHAC1 | CTSH | CXCR4 | DDIT3 | DDIT4 | DLC1 | EPO | ERBB4 | ERCC2 | FAS | FASLG | GADD45A | GAS2 | GJA1 | GPX1 | GZMA | GZMB | HMOX1 | IER3 | IFIT2 | IFNG | IGFBP3 | IL17A | IL1A | IL1B | LCK | LCN2 | LGALS1 | LGALS7 | LMNB1 | LTBR | MAPK1 | MAPK14 | MAPK3 | MAPT | MELK | NAIP | NGFR | PARP1 | PDCD4 | PHLDA2 | PURA | RNF216 | RPS3 | RRAGA | SGK1 | STK4 | TGFBR2 | TNF | TNFAIP3 | TNFRSF18 | TNFSF9 | TP53 | TRIB3 | TRP53 | XAF1 | ZFP36L1 | ZFP385A
1
49. Cyclophosphamide apoptotic process FAS [Cyclophosphamide results in increased apoptotic process] which results in increased expression of FAS 1: Homo sapiens Prostate | Cell Line, Tumor
75 genes: AKT1 | BAD | BAG1 | BAX | BCL2 | BCL2L1 | BCL2L2 | BECN1 | BIK | BIRC3 | CASP1 | CASP3 | CASP8 | CASP9 | CD14 | CD2 | CD27 | CHAC1 | CTSH | CXCR4 | DDIT3 | DDIT4 | DLC1 | EPO | ERBB4 | ERCC2 | FAS | FASLG | GADD45A | GAS2 | GJA1 | GPX1 | GZMA | GZMB | HMOX1 | IER3 | IFIT2 | IFNG | IGFBP3 | IL17A | IL1A | IL1B | LCK | LCN2 | LGALS1 | LGALS7 | LMNB1 | LTBR | MAPK1 | MAPK14 | MAPK3 | MAPT | MELK | NAIP | NGFR | PARP1 | PDCD4 | PHLDA2 | PURA | RNF216 | RPS3 | RRAGA | SGK1 | STK4 | TGFBR2 | TNF | TNFAIP3 | TNFRSF18 | TNFSF9 | TP53 | TRIB3 | TRP53 | XAF1 | ZFP36L1 | ZFP385A
1
50. Cyclophosphamide apoptotic process NAc-Sar-Gly-Val-(d-allo-Ile)-Thr-Nva-Ile-Arg-ProNEt Cyclophosphamide promotes the reaction [NAc-Sar-Gly-Val-(d-allo-Ile)-Thr-Nva-Ile-Arg-ProNEt results in increased apoptotic process] 1: Mus musculus Endothelial Cells
75 genes: AKT1 | BAD | BAG1 | BAX | BCL2 | BCL2L1 | BCL2L2 | BECN1 | BIK | BIRC3 | CASP1 | CASP3 | CASP8 | CASP9 | CD14 | CD2 | CD27 | CHAC1 | CTSH | CXCR4 | DDIT3 | DDIT4 | DLC1 | EPO | ERBB4 | ERCC2 | FAS | FASLG | GADD45A | GAS2 | GJA1 | GPX1 | GZMA | GZMB | HMOX1 | IER3 | IFIT2 | IFNG | IGFBP3 | IL17A | IL1A | IL1B | LCK | LCN2 | LGALS1 | LGALS7 | LMNB1 | LTBR | MAPK1 | MAPK14 | MAPK3 | MAPT | MELK | NAIP | NGFR | PARP1 | PDCD4 | PHLDA2 | PURA | RNF216 | RPS3 | RRAGA | SGK1 | STK4 | TGFBR2 | TNF | TNFAIP3 | TNFRSF18 | TNFSF9 | TP53 | TRIB3 | TRP53 | XAF1 | ZFP36L1 | ZFP385A
1
1–50 of 268 results.